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Salmonella enterica serovar Typhimurium (Salmonella Typhimurium) infection of chickens that are more than a few
days old results in asymptomatic cecal colonization with persistent shedding of bacteria. We hypothesized that
while the bacterium colonizes and persists locally in the cecum it has systemic effects, including changes to
metabolic pathways of skeletal muscle, influencing the physiology of the avian host. Using species-specific peptide
arrays to perform kinome analysis on metabolic signaling pathways in skeletal muscle of Salmonella Typhimurium
infected chickens, we have observed key metabolic changes that affected fatty acid and glucose metabolism
through the 5'-adenosine monophosphate-activated protein kinase (AMPK) and the insulin/mammalian target of
rapamycin (mTOR) signaling pathway. Over a three week time course of infection, we observed changes in the
phosphorylation state of the AMPK protein, and proteins up and down the pathway. In addition, changes to a large
subset of the protein intermediates of the insulin/mTOR pathway in the skeletal muscle were altered by infection.
These changes occur in pathways with direct effects on fatty acid and glucose metabolism. This is the first report of
significant cellular metabolic changes occurring systemically in chicken due to a Salmonella infection. These results
have implications not only for animal production and health but also for the understanding of how Salmonella
infection in the intestine can have widespread, systemic effects on the metabolism of chickens without disease-like
symptoms.Introduction
Salmonella are enteric bacteria, and salmonellosis is a
major infectious disease around the world. A number of
Salmonella serovars are responsible for human disease
with symptoms ranging from gastroenteritis to sepsis
[1]. Salmonella are important zoonotic agents that infect
a wide variety of animal species. Salmonella enterica
serovar Typhimurium (Salmonella Typhimurium) is a
rod-shaped, flagellated, aerobic, Gram-negative bacter-
ium. Salmonella Typhimurium is infectious to humans
and can cause severe gastro-intestinal pathology and
typhoid fever.
Salmonella Typhimurium infection of day-old chickens
can result in severe inflammatory responses and intestinal
pathology [2]; however, Salmonella Typhimurium infec-
tion in older chickens does not cause overt pathogenic* Correspondence: ryan.arsenault@usask.ca
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reproduction in any medium, provided the orsymptoms [3]. The lack of pathology observed in week-old
birds infected with Salmonella Typhimurium may be due
to a lack of a pro-inflammatory cytokine response and a
release of TGF-β4 in these older birds [4]. Despite the lack
of obvious disease symptoms and pathology, it is clear that
profound changes are occurring in the chicken host, and
many of these changes have not been fully characterized.
Peptide arrays for kinome analysis have been utilized
by a number of groups to study cellular signaling, ran-
ging from the study of cancer [5] to bacterial ligands [6].
A more recent advancement has been the use of species-
specific peptide arrays for kinomic study of less common
research species such as bovine and ovine [7]. In
addition, the use of these species-specific peptide arrays
has branched out beyond the original host-bacterial [8]
and host-viral [9] interaction studies to consider diverse
biological phenomena such as prion biology [10]. As so
much cellular function is controlled by protein phos-
phorylation, it is possible to consider other biologicalral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cycle regulation. Here, we introduce a chicken species-
specific peptide array purposely designed for the study
of cellular metabolic signaling. To our knowledge, this is
the first use of a peptide array for kinomic study of this
species and this cellular function.
The fact that alterations to the intestinal environment
affect animal growth has been known for many years.
Growth-promoting antibiotics are thought to carry out
their function through reduced local inflammation, re-
duced intestinal size and, most importantly, reduced
competition for nutrients in the small intestine [11].
Studies have shown that the population makeup of the
gut microbiota is altered by the administration of growth
promoting antibiotics [12]. It is reasonable to assume
that an infection of the intestinal tract would influence
metabolism as well, since it would likely compete with
other bacterial species in the gut and possibly affect in-
flammation: two processes known from antibiotic stud-
ies to affect animal growth [11].
The 5'-adenosine monophosphate-activated protein
kinase (AMPK) enzyme is a key metabolic energy
homeostasis regulator in avian species [13]. One of its
roles is to monitor the ratio of AMP:ATP and alter
metabolic processes accordingly. In addition, AMPK can
receive signals of cellular energy state and send corre-
sponding signals, via phosphorylation, that can affect
cellular processes such as glycolysis/gluconeogenesis,
protein synthesis, fatty acid synthesis and fatty acid
oxidation. AMPK activity is known to be affected by
changes in the gut microbiota though the mechanism is
unclear [14].
The insulin signaling pathway and mammalian target
of rapamycin (mTOR) signaling are extensively linked
and display significant overlap, so much so that it is re-
ferred to as the insulin/mTOR signaling pathway [15].
mTOR signaling plays an important role in cellular me-
tabolism and has been linked to obesity and diabetes.
Experimentally altered gut microbiota in mice has led to
obesity, metabolic syndrome and insulin resistance: dis-
orders related to the insulin/mTOR signaling pathway
[16]. While there appear to be significant differences be-
tween mammalian and avian responses to insulin, to the
point where chickens have been described as insulin re-
sistant [17], the key constituents of the insulin/mTOR
signaling pathway are similar. Despite the differential
sensitivity to insulin, evidence suggests that chickens still
respond to insulin; despite questions on the exact nature
of the pathway between the insulin receptor and Akt, all
of the members of the pathway appear to be present in
the chicken proteome [18]. The mTOR pathway appears
well conserved between mammals and chickens, though
the level of conservation among peptides upstream re-
mains a question. Based on the evidence, it is possible toassume that the mTOR pathway may play a role in
abnormal metabolism that is similar to that seen in
humans or mice. Such similarity seems likely, especially
considering how AMPK has been extensively studied in
avian species and how AMPK is involved in mTOR
signaling.
In this study, we used a chicken-specific global meta-
bolic peptide array to study the changes in skeletal
muscle metabolism over time following Salmonella
Typhimurium infection. We hypothesized that while the
bacterium colonizes and persists locally in the cecum, it
has systemic effects influencing the metabolism of skeletal
muscle. While this may not be a direct immunological ef-
fect, a disruption in metabolism and energy resources can
have a profound effect on the health of the host. Our re-
sults clearly point to alterations in AMPK phosphorylation
and activity as well as significant disruptions in the insu-
lin/mTOR signaling pathway involving numerous pathway
intermediates. We subsequently confirmed these results




These studies were approved by the Animal Care and Use
Committee (ACUC) at the Southern Plains Agricultural
Research Center, Agricultural Research Service, United
States Department of Agriculture (ACUC #2012007),
which meets all federal requirements as defined in the
Animal Welfare Act, the Public Health Service Policy, and
the Humane Care and Use of Laboratory Animals.
Animal hatch and infection
Fifty 17-day-old broiler eggs, which had not been
vaccinated or otherwise treated, were procured from
Sanderson Farms (Bryan, TX, USA). These eggs were in-
cubated at 37.2°C and 92% humidity for 3 days before
hatching. Forty of 50 eggs hatched after 3 days. Five days
post-hatch, half were orally infected with 1 × 105 cfu of
Salmonella Typhimurium that had been grown in tryptic
soy broth with 20 ug/mL novobiocin and 25 ug/mL
nalidixic acid. Control and infected animals were kept
in separate isolation rooms, and cross-contamination
was strictly controlled for. At 24 h, 96 h, 1 week and 3
weeks post infection, animals were sacrificed and sam-
ples were collected.
Sample collection
At 24 h, 96 h, 1 week and 3 weeks post infection, birds
were sacrificed by CO2 asphyxiation and muscle samples
were collected. Muscle samples from the thigh were re-
moved and immediately flash frozen in liquid nitrogen to
preserve kinase enzymatic activity. Samples were taken
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until further experimental procedures were conducted.
Peptide arrays
At each of the 4 time points and under each condition
(infected and uninfected), 3 muscle samples from 3
different animals were taken from storage for analysis
(24 samples total). Muscle samples were weighed to ob-
tain a consistent 40 mg samples for the array protocol.
Samples were homogenized by a hand-held Qiagen
TissueRuptor (Valencia, CA, USA) in 100 uL of lysis
buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,1 mM
EDTA, 1 mM Ethylene glycol tetraacetic acid (EGTA),
1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
Na3VO4, 1 mM NaF, 1 μg/mL leupeptin, 1 g/mL
aprotinin and 1 mM Phenylmethylsulphonyl fluoride (all
products from Sigma Aldrich (St. Louis, MO, USA), un-
less indicated)). Following homogenization, the peptide
array protocol was carried out as per Jalal et al. [7] with
alterations described in Arsenault et al. [8].
Antibody arrays
The mTOR Signaling Phospho-Specific Antibody Array
and antibody array assay kit were procured from Full
Moon BioSystems (Sunnyvale, CA, USA). This technique
was used as an alternative to procuring phosphospecific
antibodies individually and performing several western
blot assays. Protocol was carried out as per manufac-
turer’s instructions with the following alteration to the
homogenization step: instead of using the bead and vor-
tex homogenization indicated in the kit, the hand-held
Qiagen TissueRuptor was used.
Data analysis
Data normalization and PCA analysis was performed for
both the peptide and antibody microarrays as per Li et al.
[19]. This consistent analysis method facilitated a more
direct comparison between the two distinct array datasets
and allowed for a statistically robust analysis of the phos-
phorylation events being measured. Geneontology (GO)
and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway analysis was performed by uploading the statisti-
cally significant peptide lists to the Search Tool for the Re-
trieval of Interacting Genes (STRING) [20].
Results
Non-vaccinated, non-treated broiler eggs were procured
and hatched. Five days post-hatch, half the chicks were
orally infected with 1 × 105 cfu of Salmonella Typhi-
murium. Control and infected animals were kept in
separate isolation rooms, and cross-contamination was
strictly controlled for. At 24 h, 96 h, 1 week and 3 weeks
post infection, animals were sacrificed and samples col-
lected. Infection status was confirmed by SalmonellaTyphimurium culturing of cecal contents and feces from
each animal with and without enrichment. Cultures con-
firmed that the infected group displayed Salmonella infec-
tion throughout the experiment, while Salmonella was
not isolated from animals in the control group. Samples
were snap-frozen in liquid nitrogen as quickly as possible
to preserve enzymatic activity.
Chicken-specific peptide arrays designed for the study
of chicken metabolic signaling pathways were used to
analyze 24 thigh muscle samples. The results from the
three animals from each condition (infected and unin-
fected) and time point were averaged together to provide
a representative result (Additional file 1). PCA was
conducted on the resultant data, and distinct patterns of
clustering were observed (Figure 1). The infected birds
from the later three time points (96 h, 1 week and 3
week) clustered together, while the 24 h post-infection
birds were separate. The control data at each of the time
points did not cluster in any appreciable pattern. This
was not unexpected, as very large metabolic changes
would be occurring within these animals as they grew
from days-old chicks to weeks-old birds, making the
metabolic patterns at these time points very distinct.
To account for any changes in phosphorylation state
that were not due to the infection, the results at each
time point were corrected using their respective time-
matched controls. All peptides that showed statistically
significant differential phosphorylation (p < 0.05) for
each time point were input into the Search Tool for the
Retrieval of Interacting Genes (STRING) database [20].
Using STRING functionality, Geneontology (GO) results
for biological processes and molecular functions, as well
as Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway results were generated from each dataset.
The KEGG pathway results generated from STRING
showed a large number of pathways implicated by the
data at a statistically significant level (p < 0.05 false
discovery rate (FDR) corrected) (Table 1). Of particular
interest were those pathways that showed statistically
significant changes at multiple time points over the
course of the study. These pathways are shown in bold
in Table 1. Of note are the large number of metabolic
and immunologic pathways that have been altered by
the infection. These pathways included Adipocytokine
signaling, Fc receptor pathway, glycolysis/gluconeogene-
sis, insulin signaling, mTOR pathway and Toll-like re-
ceptor signaling. The central signaling pathway MAPK
also appeared affected by the infection at multiple time
points. The changes in MAPK and metabolic signaling
were likely the reasons why a number of cancer path-
ways were generated by the data. Though deregulation
of MAPK intermediates and changes in metabolic regu-
lation are hallmarks of cancer, cancer is very unlikely to
be the result of Salmonella Typhimurium infection; thus
Figure 1 Principal component analysis of averaged peptide array results. For each condition, samples were collected from 3 animals and
peptide arrays were performed. Following normalization, data from each treatment was averaged together to generate a representative data set
for each condition. Then PCA was performed on each of these representative data sets. Each data point represents 3 biologically distinct animals.
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intermediates within the pathways themselves should be
considered.
Using STRING GO analysis, the Molecular Function
results generated for each time point were very similar.
The most significant results related to adenyl phosphate
moiety binding. Note that all the following results were
FDR corrected. At 24 h, the top three results were
adenyl ribonucleotide binding (p-value 5.77 × 10-15),
adenyl nucleotide binding (p-value 5.77 × 10-15) and
ATP binding (p-value 2.0 × 10-14). At 96 h, the top two
results were adenyl ribonucleotide binding and adenyl
nucleotide binding (both p-value 9.1 × 10-5). At 1 week,
one of the top results was ATP binding (p-value 4.93 ×
10-4). At 3 weeks, the top result was AMP-activated pro-
tein kinase activity (p-value 1 × 10-5), and the fourth and
fifth results were adenyl ribonucleotide binding (p-value
4.8 × 10-5) and adenyl nucleotide binding (p-value 4.8 ×
10-5) respectively. These results strongly implicated a
central role for signaling events associated with the ATP,
ADP and/or AMP levels, all of which play a role as en-
ergy currency in cells.
Again using the functionality in STRING, GO Bio-
logical Process results were generated from the data for
each time point. Table 2 shows the top results for each
time point excluding generic results that provide no
relevant information. For example, processes such as“protein phosphorylation”, “enzyme linked receptor pro-
tein signaling pathway” and “intracellular signal trans-
duction” were excluded. The results provided convincing
evidence for some type of involvement of the insulin/
glucose and fatty acid metabolic pathways in Salmonella
Typhimurium infection. The Biological Process results,
the KEGG pathway analysis and the molecular function
results all provided evidence of altered metabolic activity
upon infection.
Following the higher-order analysis, we considered the
individual phosphorylation events and changes that oc-
curred over the course of the study. A subset of AMPK-
associated phosphorylation events were found to be
significantly altered over the time course of the study.
This enzyme functions as part of the energy homeosta-
sis system in cells [13]. AMPK is activated by increased
levels of AMP, which is a signal of low energy levels in
the cell. AMPK has links to fatty acid metabolism, glu-
cose uptake and insulin signaling. These pathways and
processes were implicated in our previous analysis re-
sults. AMPK is made up of three subunits: an enzymatic
kinase subunit (alpha) and two regulatory subunits (beta
and gamma) [13]. Peptide array results indicated increased
phosphorylation of AMPKα2 at S377 and decreased phos-
phorylation of AMPKβ2 S110 and AMPKγ3 S148 at 24 h
post infection. At 3 weeks post infection, there was de-
creased phosphorylation of AMPKα2, as well as AMPKα1,
Table 1 KEGG Pathways generated by STRING
24 h 96 h 1 week 3 weeks
















hsa05221 Acute myeloid leukemia 4 0.0227 3 0.0344 2 0.228 3 0.0785
hsa04520 Adherens junction 4 0.0506 2 0.340 2 0.332 4 0.0302
hsa04920 Adipocytokine signaling pathway 6 0.0023 N/S 4 0.0131 7 0.0003
hsa04360 Axon guidance 6 0.0191 4 0.0432 N/S N/S
hsa04662 B cell receptor signaling pathway 5 0.0123 3 0.0559 N/S 4 0.0297
hsa04020 Calcium signaling pathway 5 0.166 N/S 6 0.0095 N/S
hsa04062 Chemokine signaling pathway 4 0.469 5 0.0344 4 0.126 N/S
hsa05220 Chronic myeloid leukemia 4 0.0452 4 0.0103 2 0.318 6 0.0012
hsa05210 Colorectal cancer N/S 4 0.0066 N/S 3 0.0969
hsa05213 Endometrial cancer 3 0.0976 4 0.0047 N/S N/S
hsa04012 ErbB signaling pathway 8 0.0001 7 0.0000 4 0.0167 5 0.0097
hsa04664 Fc epsilon RI signaling pathway 7 0.0006 5 0.0029 N/S 6 0.0018
hsa04666 Fc gamma R-mediated phagocytosis 4 0.0979 4 0.0224 N/S 5 0.0148
hsa04510 Focal adhesion 8 0.0123 6 0.0115 N/S 7 0.0154
hsa05214 Glioma 7 0.0001 3 0.0432 6 0.0001 5 0.0033
hsa00010 Glycolysis/Gluconeogenesis 5 0.0064 3 0.0432 3 0.0586 6 0.0008
hsa04912 GnRH signaling pathway 7 0.0015 5 0.0047 4 0.0245 5 0.0151
hsa05410 Hypertrophic cardiomyopathy (HCM) 3 0.264 N/S 3 0.106 6 0.0018
hsa04910 Insulin signaling pathway 13 0.0000 10 0.0000 7 0.0003 16 0.0000
hsa04730 Long-term depression 4 0.0449 3 0.0537 4 0.0113 N/S
hsa04010 MAPK signaling pathway 14 0.0001 13 0.0000 4 0.318 11 0.0011
hsa05218 Melanoma 4 0.0443 4 0.0095 4 0.0113 5 0.0043
hsa04150 mTOR signaling pathway 6 0.0004 3 0.0309 N/S 5 0.0018
hsa04722 Neurotrophin signaling pathway 6 0.0176 6 0.0020 5 0.0113 7 0.0018
hsa05223 Non-small cell lung cancer 5 0.0048 3 0.0362 N/S 4 0.0151
hsa05212 Pancreatic cancer 4 0.0418 3 0.0476 N/S 4 0.0227
hsa05200 Pathways in cancer N/S N/S 6 0.0639 9 0.0151
hsa04914 Progesterone-mediated oocyte maturation 5 0.0176 N/S N/S 5 0.0097
hsa05215 Prostate cancer 5 0.0192 4 0.0173 4 0.0169 5 0.0107
hsa04810 Regulation of actin cytoskeleton 6 0.104 6 0.0115 N/S 6 0.0591
hsa05211 Renal cell carcinoma 4 0.0446 5 0.0018 N/S 4 0.0254
hsa05222 Small cell lung cancer N/S N/S 2 0.397 6 0.0020
hsa04660 T cell receptor signaling pathway 6 0.0123 4 0.0344 N/S 3 0.332
hsa04620 Toll-like receptor signaling pathway 5 0.0403 5 0.0058 N/S 6 0.0043
hsa04270 Vascular smooth muscle contraction 5 0.0452 3 0.139 N/S 4 0.105
hsa04370 VEGF signaling pathway 6 0.0023 N/S N/S 4 0.0302
Peptides that displayed a statistically significant change in phosphorylation state were input into the STRING database for each time point. Generated pathways
that displayed a p-value of less than 0.05 (FDR corrected) are listed. Pathways that displayed statistical significance at three or more time points are shown in
bold. N/S indicates that the pathway is Non-significant as no peptides were found within the pathway.
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(Figure 2).
Other phosphorylation events provided further evi-
dence for the early activation of AMPK. Calcium/cal-
modulin-dependent protein kinase II (CaMK2) is knownto affect AMPK phosphorylation [21]. Results showed
that CaMK2 beta (the most active form of CaMK2) was
phosphorylated 2.73 fold (p 0.005) over control at the 24
h time point. Also, AMPK is known to inhibit protein
synthesis through phosphorylation-mediated inhibition
Table 2 GO Biological processes
24 h 96 h 1 week 3 weeks








GO:0006112 energy reserve metabolic
process
11 1.62E-07 8 3.71E-06 N/S 8 9.87E-06
GO:0008286 insulin receptor signaling
pathway
11 2.43E-07 6 3.09E-04 N/S 9 3.49E-05
GO:0019217 regulation of fatty acid
metabolic process
8 2.04E-06 4 2.75E-03 2 3.82E-01 8 2.27E-07
GO:0006091 generation of precursor
metabolites and energy
13 1.59E-05 10 1.99E-05 N/S 9 8.88E-02
GO:0031325 positive regulation of cellular
metabolic process
23 7.10E-04 18 2.11E-05 N/S 21 2.66E-07
GO:0005978 glycogen biosynthetic process 3 3.17E-03 2 3.44E-02 3 3.67E-03 N/A
GO:0016051 carbohydrate biosynthetic
process
7 4.06E-04 3 1.62E-01 5 4.62E-03 7 5.64E-05
GO:0046320 regulation of fatty acid
oxidation
6 1.32E-05 2 1.67E-01 N/S 7 1.08E-07
Peptides that displayed a statistically significant change (FDR corrected) in phosphorylation state were input into the STRING database for each time point. The top
generated GO Biological Process results for each time point are listed, excluding generic results that are inherent to the analysis such as "protein phosphorylation",
"enzyme linked receptor protein signaling pathway" and "intracellular signaling transduction". These provide no relevant data for analysis. N/S indicates that the
pathway is Non-significant as no peptides were found within the pathway.”
Figure 2 AMPK related phosphorylation changes relative to control over time. Comparison of Salmonella Typhimurium infected to
uninfected muscle samples at each time point generate a phosphoylation fold change and a statistical significance value for each peptide on the
array. The * indicates statistically significant difference in phosphorylation relative to control (p < 0.05).
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but not S78 or S366 [22]. Peptide array results showed
that EF2K S398 phosphorylation was increased 1.97 fold
(p 0.017) at the 24 h time point. This was the same time
point that showed the greatest AMPKα phosphorylation.
The EF2K S78 peptide target was also present on the
peptide array, but since this site phosphorylation is not
affected by AMPK in vivo [22] it showed no significant
phosphorylation at any time point as expected.
The later time points showed a reduced phosphoryl-
ation of AMPKα. One of the effects of reduced AMPK
activity is a decrease in fatty acid oxidation and an in-
crease in fatty acid and cholesterol synthesis [13]. We
saw evidence that fatty acid metabolism was altered over
the course of the study, as two of the GO biological
processes implicated by the peptide array data were
“regulation of fatty acid metabolic processes” and “regu-
lation of fatty acid oxidation”, the latter only displayed
significance at the 3 week time point. In a comparison
of fat and lean birds, it has been shown that fat birds
had reduced AMPK gene expression and reduced
AMPKα phosphorylation [23]. This protein appears to
be one of the key determinants of whether a bird is con-
sidered fat or lean. Besides AMPK, two peptides showed
significant differential phosphorylation over numerous
time points, are known to be involved in fatty acid pro-
cesses and displayed increased phosphorylation over
time (Figure 3). These were cytosolic phospholipase A2
(cPLA2), which has been implicated previously in fatty
acid metabolism [24], and carnitine palmitoyltransferase
1A (CPT1A), which is related to fatty acid metabolism
in mitochondria [25].
Acetyl-coenzyme A carboxylase 1 (ACC1) is an en-
zyme which is involved in long chain fatty acid synthesis.
ACC1 activity is inhibited by phosphorylation at two
sites: S80 (S79 in mice), which was not present on the
peptide array, and S1263, ortholog of S1255 in chicken
[26]. Peptide array results showed that there was a 2.18Figure 3 Fatty acid related peptide changes relative to control over t
muscle samples at each time point generate a phosphoylation fold change
* indicates statistically significant difference in phosphorylation relative to cfold change (p 0.042) increase in phosphorylation of
S1255 of ACC1 at the 24 h time point. This change indi-
cates early inhibition of fatty acid synthesis. At later time
points, this phosphorylation site showed no significant
phosphorylation indicating no inhibition of this enzyme
and the potential for fatty acid synthesis. PPAR gamma
co-factor 1 (PGC-1) is an enzyme which is present in
adipose cells and skeletal muscle, and it coordinates fatty
acid catabolism and thermogenesis [27]. At the 3 week
time point, this protein was shown to be significantly
dephosphorylated (−2.46 p-value 0.03). With the elimin-
ation of PGC-1 activity, the signal to initiate fatty acid
catabolism would be lost. Both the loss of PGC-1 and
the loss of inhibition ACC1 lead to increased fatty acid
stores in the muscle. The above results can all proceed
from a change in AMPK activity over time brought
about by the Salmonella Typhimurium infection. The re-
sult of this infection-induced AMPK change may be a
disruption of the normal metabolic functions within the
muscle of the birds.
Based on the pathway and GO results described
previously insulin signaling appeared to be affected by
the infection. The KEGG insulin pathway showed a sta-
tistically significant change due to the infection at all
time points (Table 1), and the GO Biological Process in-
sulin receptor signaling pathway showed a statistically
significant change at 24 h post infection (Table 2). In
addition, the mTOR pathway showed statistically signifi-
cant changes at three of the four time points. Due to the
significant overlap between the two pathways, and the
fact that many pathway intermediates appear in the pep-
tide array analysis, we will consider a combined insulin/
mTOR pathway in our analysis [15]. Several peptides
representing protein phosphorylation sites known to be
involved in the insulin/mTOR pathway showed signifi-
cant change in phosphorylation state over multiple time
points (Figure 4). The two branches of the insulin/
mTOR signaling pathway are affected by the Salmonellaime. Comparison of Salmonella Typhimurium infected to uninfected
and a statistical significance value for each peptide on the array. The
ontrol (p < 0.05).
Figure 4 Insulin/mTOR peptide changes relative to control over time. Comparison of Salmonella Typhimurium infected to uninfected
muscle samples at each time point generate a phosphoylation fold change and a statistical significance value for each peptide on the array. The
* indicates statistically significant difference in phosphorylation relative to control (p < 0.05).
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protein kinase (MAPK) signaling and phosphoinositide
3-kinase (PI3K)/Akt (also known as Protein Kinase B)
signaling. The majority of the peptides that had signifi-
cant changes over multiple time points are part of the
MAPK branch. Raf, mitogen-activated protein kinase kin-
ase kinase 3 (MEKK3), mitogen-activated protein kinase
kinase 4 (MKK4), mitogen-activated protein kinase kinase
6 (MKK6) and TAB1 are all part of MAPK-related signal-
ing. In the PI3K branch at the 3 week time point, the
phosphoinositide 3-kinase regulatory subunit 1 (PIK3R1)
is activated by the phosphorylation ofY528 [28]. This
phosphorylation indicates that at least part of the PI3K/
Akt pathway is still active or is being activated by changes
caused by the infection at the later time points.
The function of insulin and its signaling pathway is in-
timately related to glucose metabolism. Indeed, one ofthe major functions of insulin is to stimulate the uptake
of glucose by cells. Again considering the peptides that
display significant differential phosphorylation at mul-
tiple time points, we see several peptides involved in
glucose metabolism with a consistent change in response
(Figure 5). Enolase 1 (ENO1), 6-phosphofructokinase,
muscle type (PFKM) and glycogen phosphorylase
(PYGL) all displayed increasing phosphorylation over
the course of the experiment. Conversely, phosphoglu-
comutase 2-like 1 (PGM2L1) showed decreasing phos-
phorylation. PGM2L1 is an anabolic enzyme, and its
decreased activation at the later time points while the
other catabolic peptides were activated indicates an in-
crease in the glucose-consuming response.
Overall, the results showed that the Salmonella
Typhimurium infection has a number of effects on the
insulin/mTOR pathway. Effects can be seen at various
Figure 5 Glucose related peptide changes relative to control over time. Comparison of Salmonella Typhimurium infected to uninfected
muscle samples at each time point generate a phosphoylation fold change and a statistical significance value for each peptide on the array. The
* indicates statistically significant difference in phosphorylation relative to control (p < 0.05).
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and glucose related signaling. Considering the specific
peptides described which showed differential phosphoryl-
ation over the course of the study, it is clear why insulin,
mTOR, glycolysis/gluconeogesis and MAPK pathways
were implicated by the KEGG pathway analysis generated
by the STRING database (Table 1).
Antibody peptide array: validation of kinome analysis
One of the standard methods for validating kinomic
peptide array data is the use of phosphospecific anti-
bodies. Normally, western blots using antibodies for spe-
cific phosphorylation events are performed to confirm
the individual phosphorylation events reported by the
array. This validation is akin to performing quantitative
real-time polymerase chain reaction on individual genes
to validate cDNA microarray data. We chose a slight
variation of that standard validation processes. We
employed an antibody microarray containing both pan-
specific and phospho-specific antibodies. Despite the
scarcity of chicken-specific antibodies, the key proteins
of interest based on the peptide array results were
relatively well conserved between humans and chickens,
giving us confidence that we would observe significant
cross-reactivity from the antibodies. The percent or-
thology between the human and chicken 15 amino acid
phosphorylation target sites (as determined by NCBIProtein Blast analysis) is shown in Table 3. An antibody
array covering the mTOR pathway was used. Comparing
1 week infected samples to 24 h infected samples allowed
us to observe changes in the infected animal muscle at
an early to late time course. Similarly, we were analyzing
changes in phosphorylation over the early to late stages
of infection with the peptide arrays. Following data
normalization, the results pointed to a similar pattern to
that observed with the peptide arrays (Table 3).
Analysis of the antibody array data via the STRING
data based showed that the top two KEGG pathways
were insulin signaling pathway (p value 9.50 × 10-10) and
mTOR signaling pathway (p value 1.08 × 10-7). GO
biological processes indicated insulin receptor signaling
pathway (p value 2.98 × 10-6), and GO molecular
function showed ATP binding (p value 1.14 × 10-3). All
of these results were in agreement with the peptide
array data. In addition, specific results such as the de-
phosphorylation of AMPK, activation of insulin recep-
tor, activation of Akt (S374) and shutting down of the
mTOR pathway (decreases in P70S6K, 4E-BP1 and
eIF4E) are in agreement with peptide array results.
Discussion
Peptide array kinome analysis has been used for the
study of various cell biology questions [5,6]. In addition,
species-specific peptide arrays have been employed to
Table 3 Antibody array results
Protein name (phosphorylated residue) Fold change antibody array P -value Orthology Fold change peptide array
4E-BP1 (Phospho-Ser65) −1.43712 0.00137 93% N/A
4E-BP1 (Phospho-Thr70) −1.36207 0.013516 86% N/A
AKT (Phospho-Ser473) 1.579649 0.002667 100% 1.61614
AKT (Phospho-Thr308) 1.898775 0.003797 100% 1.31019
AKT1 (Phospho-Ser124) −1.47999 0.000402 100% N/A
AKT1 (Phospho-Thr450) −1.5584 0.000476 100% N/A
AKT1S1 (Phospho-Thr246) −1.79817 2.22E-05 0% N/A
AMPK1 (Phospho-Thr174) −1.22623 0.0154 100% −1.09134
AMPKbeta1 (Phospho-Ser182) −1.34017 0.029026 93% −1.10925
BAD (Phospho-Ser112) 1.40376 0.012781 78% N/A
BAD (Phospho-Ser134) 1.380989 0.020394 0% N/A
BAD (Phospho-Ser136) 1.29749 0.039652 0% N/A
eIF4E (Phospho-Ser209) −1.33384 0.030631 100% N/A
ERK3 (Phospho-Ser189) 1.210088 0.019255 100% 4.01876
GSK3 beta (Phospho-Ser9) 2.974451 0.002007 100% 1.12689
IR (Phospho-Tyr1355) 3.187483 2.62E-05 53% N/A
IR (Phospho-Tyr1361) 1.685564 0.012336 93% N/A
P70S6K (Phospho-Ser371) −1.73418 0.000111 100% N/A
P70S6K (Phospho-Ser418) −1.58607 0.000109 100% N/A
P70S6K (Phospho-Ser424) −1.39268 0.037721 100% N/A
P70S6K (Phospho-Thr229) −1.44379 0.000416 100% N/A
P70S6K (Phospho-Thr389) −1.84347 0.009943 100% −1.12207
P70S6K (Phospho-Thr421) −1.22221 0.013127 100% N/A
P70S6k-beta (Phospho-Ser423) 1.60054 0.000107 100% N/A
P90RSK (Phospho-Ser380) 1.255345 0.04783 100% −1.12470
PDK1 (Phospho-Ser241) 1.632697 0.002201 93% −1.01557
PI3-kinase p85-alpha (Phospho-Tyr607) −1.3092 0.038374 87% −1.34043
PIP5K (Phospho-Ser307) −1.2407 0.026195 100% N/A
PTEN (Phospho-Ser370) 1.491624 0.002252 100% N/A
PTEN (Phospho-Ser380) 1.533421 0.005982 100% 1.12240
Statistically significant (p < 0.05) phosphospecific antibody array analysis results of Salmonella Typhimurium infected muscle samples. One week post-infection
samples were compared to 24 h post-infection samples to find changes in infected muscle over time. Antibodies due to being bound to phosphorylated protein
had a statistically significant difference in fluorescent signal are shown. Fold Change Antibody Array is the change in fluorescent signal when comparing the 1
week and 24 h infected samples as indicated by the antibody array. Orthology indicates the % similarity between human and chicken at the 15 amino acid region
flanking the phosphorylation residue. Fold Change Peptide Array is the change in fluorescent signal when comparing the 1 week and 24 h infected samples as
indicated by the peptide array. N/A indicates the exact phosphorylation target residue on the antibody array was not present on the peptide array.
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other than humans or mice [8,9]. This technique has un-
covered novel biology and advanced our understanding
of a number of biological processes and disease states
[8-10]. In this study, we have used the species-specific
peptide arrays to uncover metabolic signaling changes in
chicken skeletal muscle due to Salmonella Typhimurium
infection. To our knowledge, this study incorporates a
number of firsts in the field of kinomics: the first
published use of a chicken-specific peptide array, the
first study of metabolic processes using a kinome arrayand the first study of systemic phosphorylation-mediated
metabolic changes brought about by a gastrointestinal
infection.
The results of this study clearly point to changes in
key, related, metabolic processes upon Salmonella
Typhimurium infection: insulin/mTOR/glucose, fatty
acid and AMPK related signaling. Metabolic changes in
peripheral tissue as a result of infection have been
reported previously [29]; however, metabolic changes as
a result of a sub-clinical infection, especially one that is
considered well tolerated such as a Salmonella
Figure 6 AMPK energy influence. The phosphorylated, active form
of AMPK exerts effects that lead to an increase in ATP-producing
functions and a decrease in ATP-consuming functions. When AMPK
is not phosphorylated, these signals are not present, rather, the ATP
producing signals are now present, and the ATP consuming
functions are able to occur.
Arsenault et al. Veterinary Research 2013, 44:35 Page 11 of 15
http://www.veterinaryresearch.org/content/44/1/35Typhimurium infection in chicken, has not previously
been shown. To our knowledge, this is the first study
demonstrating that Salmonella Typhimurium infection
of the chicken cecum has potential systemic effects on
metabolism/physiology. The consequences of this may
be a direct effect on animal performance, including
muscle quality, immunity and overall health.
AMPK is a key metabolic regulator. Through AMP
binding domains and phosphorylation sites for a number
of metabolic related kinases, AMPK can receive signals
of cellular energy state and then send corresponding sig-
nals via phosphorylation [13]. These signals can affect
cellular processes such as glycolysis/gluconeogenesis,
protein synthesis, fatty acid synthesis and fatty acid oxi-
dation, among others (Figure 6). Clear changes in AMPK
phosphorylation state were observed at various time
points following infection with Salmonella Typhimurium.
Phosphorylation sites on all three of the AMPK subunits
displayed differential phosphorylation based on the pep-
tide array data, and both alpha and beta subunits showed
significant change between the 24 h and 1 week post in-
fection time points on the antibody arrays. The decreased
phosphorylation of AMPKα, which is shown by both the
peptide array and antibody array techniques, indicates that
AMPK activity is decreasing over time. Active AMPK,
seen at the early time points, would lead to the activation
of catabolic, ATP producing functions such as glycolysis
and fatty acid oxidation. At the later time points where a
decreased phosphorylation of AMPKα is observed, the ef-
fect would be a decrease in ATP producing functions and
an increase in anabolic, ATP consuming activities such as
lipogenesis. Figure 7 shows the pathways that lead to an
early inhibition of lipogenesis that is lost over time. The
profound effects that AMPK has on lipid metabolism andwhether chicken muscle is lean or fat has been reported
previously [23]. A loss of AMPK related inhibition of lipo-
genesis could result in increased fat deposition in the
muscle of infected birds. This ATP energy consumption
could be directed toward other healthier purposes such as
immune response or building muscle. As can be observed
in Figure 7, the mTOR pathway leading to protein synthe-
sis was inactivated at the later time points of infection. It
is possible that energy is being taken from a peptide
synthesis function and consumed for a disregulated Lipo-
genesis function.
The decreased phosphorylation of AMPKα would nor-
mally lead to an increase in gluconeogenesis (an ATP
consuming function) and a decrease in glycolysis. As can
be observed in the phosphorylation states of several glu-
cose related proteins (Figure 5) and the insulin/mTOR
pathway (Figure 7), glycolysis actually increases over
time, and there is an active inhibition of gluconeogensis
as evidenced by the phoshorylation of GSK3β and PYG.
As the protein synthesis pathway appears to be inactive,
it is unlikely that the energy being mobilized by glycoly-
sis is being used to synthesize protein and build muscle.
It is possible that this glucose mobilization is a response
to a lack of energy due to the pro-anabolic, ATP con-
suming response initiated by the inhibition of AMPK.
An example of this type of response may be lipogenesis
activation. Regardless of where this energy is being used,
the mobilization of glucose stores and the lack of AMPK
signaling indicate a serious disruption of the normal
metabolic functions within the muscles of Salmonella
Typhimurium infected birds. We can see that protein
synthesis, one of the normal functions of a rapidly grow-
ing animal, is deactivated (Figure 7). The number of
links between infection, pathogenesis, immunity and
metabolism are so numerous that a consideration of me-
tabolism when studying host-pathogen interaction is
important. Taken together, these results indicate that
though Salmonella Typhimurium has been considered a
non-disease causing agent in chickens, it does result in
serious disruption of metabolic functions with potential
consequences for the normal physiological function and
health of the animal.
Results from the antibody microarray provide a further
characterization of Salmonella induced muscle metabol-
ism changes. The peptide array data at the later time
points showed that the PI3K/Akt pathway appears active
from the level of the receptor to Akt; however, mTOR
and proteins downstream appear inactive. The phos-
phorylation of proline-rich AKT1 substrate 1 (PRAS40)
(also named AKT1S1) by Akt2 at T246, shown on the
antibody array, provides further evidence for active insu-
lin related signaling. PRAS40/AKT1S1 is an inhibitor of
mTOR, but phosphorylation at T246 inhibits PRAS40/
AKT1S1 inhibition of mTOR [30]. As indicated by the
Figure 7 Pathway summary of peptide array and antibody array results. Figure displays an overview of the observed results combining
both peptide array and antibody array techniques. Phosphorylation/dephosphorylation refers to phosphorylation state of peptides comparing
infected to uninfected samples (peptide arrays) or late to early infected samples (antibody arrays). Early changes refer to differential
phosphorylation at the 24 h and/or 96 h time points. Late changes refer to differential phosphorylation at the 1 week and/or 3 week time points.
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http://www.veterinaryresearch.org/content/44/1/35peptide array Akt2 is phosphorylated at a site that would
indicate increased enzymatic activity. Akt2 then phos-
phorylates PRAS40 at T246, as shown by the antibody
array, this phosphorylation inhibits PRAS40 activity. Ac-
tive PRAS40 inhibits mTOR signaling while inhibited
PRAS40 does not. Despite PRAS40 inhibition we ob-
serve a dephosphorylation and deactivation of the
mTOR signaling pathway starting at the mTOR peptide
itself. A possible explanation for the shutting down of
mTOR activity, despite PRAS40 inhibition, is by an
alternative Akt-independent method, through phosphat-
ase and tensin homolog (PTEN) activity. The antibody
microarray shows that PTEN is phosphorylated at S370
and S380, while the current belief is that these phos-
phorylations inhibit some PTEN functions, there is as
yet no consensus on how these phosphorylation events
affect enzymatic activity specifically [31]. These data
highlight the importance of understanding the results of
individual phosphorylation events on a given protein. Anincreased phosphorylation does not always indicate acti-
vation or a dephosphorylation inactivation. Between the
peptide array and antibody microarray, we were able to
achieve good coverage of the insulin/mTOR signaling
pathway; however, numerous other proteins, which were
not included in either the peptide array or antibody
array, may be exerting their effects as well. For example,
mTOR shutdown may be a result of forkhead box
protein O1 (FOXO1) activity. FOXO1 activity was also
shown to decrease the phosphorylation and activity of
not only mTOR but also p70S6K, 4EBP1 and eIF4E [32],
all results observed in the antibody microarray. At this
later time of infection it is also possible that effector
molecules produced by Salmonella Typhimurium have
gone systemic and are altering metabolic signaling in the
peripheral muscle.
It had been assumed that an infection with Salmonella,
though dangerous from a food safety perspective, was not a
detriment to the health and growth of commercial chickens
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can be observed in skeletal muscle metabolism. The range
of ways that an infection may be altering host metabolism
is of such wide scope that substantial follow-up studies will
be required to uncover the potential mechanism(s). There
are a number of ways that a Salmonella Typhimurium in-
fection may alter muscle metabolism:
1. A transient response to early infection may activate
stress responses, including the mobilization of energy
by AMPK. Following the establishment of infection,
either the stress response may cease or AMPK may
become desensitized to the signal resulting in the
inverse response of fatty acid synthesis. This
desensitization of AMPK has been observed
previously in response to repeated exercise [33].
2. The normal gut microbiota provides a large,
complex assortment of signals, metabolites and
stimulations to the host. An infection of Salmonella
would almost certainly disrupt the normal
population balance of the gut and alter these signals
[34]. Ample evidence is emerging as to the
importance of the gut microbiota and the balance of
microbiotic populations for animal health [35]. A
persistent Salmonella infection of the chicken gut
must be exerting effects on the other bacteria
inhabiting the system. Salmonella infection has been
shown previously to cause changes in the microbial
ecology of the gastrointestinal tract of mice [36]. A
previous study has shown that an antibiotic-induced
disruption of the gut microbiota alters host
susceptibility to enteric infection [37]. Even though
Salmonella infection does not result in obvious
negative consequences to an avian host, it may
disrupt natural beneficial bacteria. It is possible that
these are the same or similar beneficial bacteria that
thrive following animal treatment with growth
enhancing antibiotics. Following antibiotic treatment
of food animals, gut microbiota populations are
disrupted and those bacteria beneficial to growth are
able to thrive [38]. In our study, the opposite may be
occurring, with Salmonella out-competing the
beneficial bacteria. The infection at later time points
causes an increase in fatty acid synthesis, a negative
consequence in terms of meat-animal production.
For many years, there has been evidence of an effect
on chicken adiposity due to infections [39].
3. Another possible cause of systemic changes in the
host is changes in hormones and/or hormone
metabolism. Salmonella Typhimurium infection has
been shown to cause large scale changes in host
hormone metabolism [40]. Metabolomic study of
the liver and feces of mice infected with Salmonella
Typhimurium showed changes in a variety ofmetabolites including those involved in fatty acid
and glucose metabolism. In addition, it was found
that significant changes in eicosanoid metabolism
intermediates occurred due to Salmonella
Typhimurium. Eicosanoids are fatty acid derived
hormones which can have systemic effects. It is
possible that the muscle metabolism changes we
have observed here are a result of changes in
hormones, specifically eicosanoids, brought about by
the intestinal infection of the host. cPLA2
phosphorylation is evidence of eicosanoid hormone
influence. cPLA2 is an enzyme that catalyzes an
early step in the biosynthesis of eiconsaoid
hormones including the prostaglandins [41]. We see
a significant increase in cPLA2 phosphorylation over
the course of this study (Figure 3), that may result in
an increase in hormone production. These
hormones may have systemic effects resulting in the
changes in muscle metabolism we have observed.
4. There are numerous nervous system connections
between the brain and gut. These connections can
influence metabolism throughout the body,
including glucose metabolism [42]. If a Salmonella
infection, either through altered gut microbiota
populations or altered gut absorption, alters these
neuronal signals, it could affect metabolism in the
entire body. A lack of nutrient absorption could
signal the body to engage energy stores in the
muscle, adipose cells or the liver, for example. Any
or all of the potential Salmonella effects on the gut
described above could affect skeletal muscle
metabolism in the ways observed in this study.
In summary, this study shows that skeletal muscle metab-
olism is altered following Salmonella Typhimurium infec-
tion, and that these alterations change over time. Early
activation of AMPK indicates an energy-producing cata-
bolic response, while late AMPK deactivation would
lead to an anabolic response which appears biased to-
ward fatty acid metabolism. The disregulation of the
mTOR/insulin signaling pathway points to altered glu-
cose metabolism throughout the time course of the
study, with a strong inhibition of glycogenesis at the
later time points. This study also adds to the growing
body of evidence pointing to the importance of gut
bacterial populations in systemic host functions.Additional file
Additional file 1: Peptide array results. Complete peptide array results
for all 300 peptides on the array and all 4 time points. Results represent
the average of 3 separate animals combined to produce a representative
result. Protein and Target Amino Acid show the protein name
represented by the peptide and phosphorylated amino acid residue
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equivalent protein. Fold change is the relative phosphorylation compared
to the time-matched control. P-value is the statistical significance of the
differential phosphorylation.
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